Free shipping on all orders over $ 500

EPI-001

Cat. No. M8699

All AbMole products are for research use only, cannot be used for human consumption.

EPI-001 Structure
Synonym:

EPI001

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

EPI-001 is a specific inhibitor of the AR (androgen receptor) without inhibiting PR or GR transcriptional activities. EPI-001 selectively interacts with transactivation unit 5 (Tau-5) of the androgen receptor, which is essential for prostate cells to proliferate in the absence of androgens. EPI-001 can inhibit transactivation of the AR amino-terminal domain (NTD), with an IC50 of ~6 μM. EPI-001 is also a selective modulator of PPARγ. 

EPI-001 (20 mg/kg; i.v. every 5 d for 25 d) inhibits the growth of tumors and has no general toxicity in vivo. EPI-001 (50 mg/kg; i.v.) blocks the androgen-axis and inhibits androgen-dependent tumor growth. 

EPI-001 is active against castration-resistant prostate cancer (CRPC) in xenografts.

Chemical Information
Molecular Weight 394.89
Formula C21H27ClO5
CAS Number 227947-06-0
Solubility (25°C) DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Eva De Mol, et al. EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor

[2] Amy E Monaghan, et al. A sting in the tail: the N-terminal domain of the androgen receptor as a drug target

[3] Lucas J Brand, et al. EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer

[4] N Agarwal, et al. New agents for prostate cancer

[5] E Andres, et al. Successful micronucleus testing with the EPI/001 3D reconstructed epidermis model: preliminary findings

Related Androgen Receptor Products
MDV3100

MDV3100 is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity.

Bicalutamide

Bicalutamide is an orally active non-steroidal androgen receptor antagonist (IC50 = 190 nM).

Ostarine

Ostarine (GTx-024 and MK-2866) is an investigational selective androgen receptor modulator (SARM) with Ki of 3.8 nM.

Andarine

Andarine (GTx-007, S-4) is a selective nonsteroidal androgen receptor (AR) agonist with Ki of 4 nM.

AZD3514

AZD3514 is a potent, orally activie and selective androgen receptor (AR) inhibitor with potential anticancer cancer activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: EPI-001, EPI001 supplier, Androgen Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.